Welcome to our dedicated page for Celestica news (Ticker: CLS), a resource for investors and traders seeking the latest updates and insights on Celestica stock.
Celestica, Inc. (CLS) is a prominent player in the realm of design, manufacturing, hardware platform, and supply chain solutions, catering to some of the world's most innovative enterprises. Established as a trusted partner, Celestica delivers end-to-end product lifecycle solutions that propel customer success through a streamlined global operations network and robust IT platform.
With an unwavering commitment to providing a distinctive customer experience, Celestica’s agile workforce is renowned for their expertise and creativity, enabling clients to overcome diverse challenges. The company's core operations are divided into two main segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS).
- Advanced Technology Solutions (ATS): This division includes Aerospace and Defense, Industrial, HealthTech, and Capital Equipment businesses. The Capital Equipment business encompasses the Semiconductor, Display, and Robotics sectors.
- Connectivity & Cloud Solutions (CCS): This segment is focused on Communications and Enterprise end markets, which include servers and storage solutions. Notably, the CCS segment contributes the majority of Celestica's revenue.
In recent developments, Celestica has expanded its portfolio by launching four new networking switches catering to enterprises' performance and connectivity needs. These switches support SONiC (Software for Open Networking in the Cloud) and boast features such as concurrent Wi-Fi connectivity and 5G LTE for WAN backhaul, making them reliable, scalable solutions aligned with the Open Compute Project (OCP) standards.
Financially, Celestica has been active in managing its share repurchase programs. Over recent periods, the company has made significant payments to repurchase subordinate voting shares (SVS) for both cancellation and delivery obligations under their SBC plans.
For more detailed information about Celestica, their offerings, and the latest updates, visit www.celestica.com.
Celestica reported Q1 2022 revenue of $1.57 billion, a 27% increase from Q1 2021, driven by strong performance across its segments. The operating margin improved to 4.4%, up from 3.5% a year ago, and adjusted EPS rose to $0.39. The company raised its full-year revenue outlook to at least $6.5 billion, expecting at least 15% growth year-over-year. However, they anticipate ongoing supply chain constraints throughout 2022, which may impact future performance.
Celestica announced that its first quarter financial results will be disclosed on April 27, 2022, after market close, followed by a conference call on April 28, 2022, at 8:00 AM ET. Participants can join the live webcast through the provided link or access a recorded version later. This event will provide insights into the company's performance, potential earnings, and future guidance, marking an important date for investors tracking stock symbol CLS.
Celestica Inc. (NYSE: CLS) held a virtual investor meeting on March 24, 2022, discussing its multi-year transformation and growth strategies. Management projected 2022 revenue of over $6.3 billion, with Lifecycle Solutions revenue anticipated to grow by at least 10%. The company aims for a non-IFRS operating margin between 4% and 5%, targeting free cash flow of at least $100 million. Non-IFRS adjusted EPS is projected to be between $1.55 and $1.75, with long-term objectives for continuous annual growth through 2025.
Celestica Inc. (NYSE: CLS) announced a virtual investor meeting on March 24, 2022, from 2:00 pm to 3:30 pm ET. During this session, management will outline their multi-year transformation and discuss strategies for growth, particularly in the Hardware Platform Solutions sector. Participants can join via dial-in numbers or through a webcast, with a recorded version available afterward for 12 months. Celestica is recognized for its customer-focused design and manufacturing solutions across various industries, including aerospace, communications, and HealthTech.
Celestica Inc. (NYSE, TSX: CLS) has filed its annual report on Form 20-F for the fiscal year ending December 31, 2021, with the U.S. SEC. This report is available on the company's website, SEDAR, and SEC's platform. Shareholders can request a free copy of the Form 20-F via email. Celestica is recognized for its customer-centric approach, providing design, manufacturing, and supply chain solutions across various industries including Aerospace, Defense, and HealthTech.
Celestica Inc. (NYSE, TSX: CLS) has announced its Annual Shareholders Meeting will take place virtually on April 28, 2022, at 9:30 a.m. EDT, due to ongoing COVID-19 concerns. The record date for shareholders entitled to vote at the meeting is set for March 11, 2022. This year, Celestica will utilize the notice-and-access method for delivering proxy materials, which shareholders can expect to receive by late March. Proxy information will also be available on the company's website and on SEDAR and EDGAR profiles.
Celestica reported strong Q4 results for 2021 with revenue of $1.5 billion, up 9% year-over-year. The company achieved a non-IFRS adjusted EPS of $0.44, the highest in over 20 years, supported by a record operating margin of 4.9%. The ATS segment led growth with a 23% revenue increase. For Q1 2022, guidance estimates revenue between $1.4 billion to $1.55 billion with adjusted EPS projected at $0.31 to $0.37. For the full year, a revenue target of at least $6.3 billion is anticipated, pending supply chain constraints remaining stable.
Celestica Inc. (NYSE: CLS) announced it will host its fourth quarter 2021 financial results conference call on January 27, 2022, at 8:00 AM EST. Financial results will be released after market close on January 26, 2022.
The event will include a webcast accessible via Celestica's Investor Relations portal. An audio replay will be available post-call.
Celestica focuses on design, manufacturing, and supply chain solutions for sectors including Aerospace, Defense, and HealthTech.